Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib

Diagnosis and Follow-Up of Keratoacanthoma-Like Lesions: Clinical-Histologic Study of 43 Cases

(2015) Renata Ferreira Magalhães et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Cutaneous Squamous Cell Carcinoma and Inflammation of Actinic Keratoses Associated with Sorafenib

(2009) Zita Dubauskas et al.   Clinical Genitourinary Cancer

Multiple Squamous Cell Carcinomas of the Skin After Therapy With Sorafenib Combined With Tipifarnib

(2008) David S. Hong et al.   ARCHIVES OF DERMATOLOGY

Prospective Study of the Cutaneous Adverse Effects of Sorafenib, a Novel Multikinase Inhibitor

(2008) Julien Autier et al.   ARCHIVES OF DERMATOLOGY

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

(2008) M. M. Hipp et al.   BLOOD

Dermatologic symptoms associated with the multikinase inhibitor sorafenib

(2008) Caroline Robert et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY